Our analysis also set out to evaluate whether smaller apo(a) isoforms had a predictive value for vascular aging different than larger apo(a) isoforms in a cohort of subjects free from cardiovascular disease (CVD). The gene discussed is LPA; the disease is cardiovascular disorder.